ATC
RLAY icon

Adirondack Trust Company’s Relay Therapeutics RLAY Stock Holding History

Adirondack Trust Company’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-344
Closed -$897 – 494
2025
Q1 		$897 Hold
344
– – ﹤0.01% 464
2024
Q4 		$1.42K Hold
344
– – ﹤0.01% 466
2024
Q3 		$2.44K Hold
344
– – ﹤0.01% 453
2024
Q2 		$2.24K Hold
344
– – ﹤0.01% 456
2024
Q1 		$2.85K Hold
344
– – ﹤0.01% 452
2023
Q4 		$3.45K Buy
+344
New +$2.9K ﹤0.01% 432

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Adirondack Trust Company's RLAY Position: Q2 2025 in Review

Adirondack Trust Company sold out of Relay Therapeutics (RLAY) in Q2 2025, closing a stake of 344 shares — an estimated $897 sold.

Adirondack Trust Company first reported a position in RLAY in Q4 2023 and held it in 6 quarters. The position peaked at $3.45K in Q4 2023. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • Adirondack Trust Company reported no remaining Relay Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Adirondack Trust Company sold 344 Relay Therapeutics shares in Q2 2025, an estimated $897.
  • Adirondack Trust Company first reported a position in Relay Therapeutics in Q4 2023 and held it in 6 quarters.
  • Adirondack Trust Company's Relay Therapeutics position peaked at $3.45K in Q4 2023.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on Adirondack Trust Company's 13F filing for Q2 2025, filed 11 Jul 2025.